GAS5 and neoplasm: Moreover, the reduced expression of GAS5-AS1 in NSCLC was associated with larger tumor size (>3 cm, P = 0.007), higher TNM stage (P = 0.012), and lymph node metastasis (P = 0.018) (Fig. 1B).